Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Care Benefits topic
No spam. Unsubscribe anytime.
County staff warn GLP-1 weight-loss/diabetes drugs are driving nearly half the pharmacy spend; commissioners acknowledge briefing
Summary
Consultants and benefits staff told commissioners six drugs — primarily GLP-1 class medications — account for roughly 48% of Cameron County’s pharmacy spend; consultants offered cost-containment options to be presented in October but no immediate plan change was approved.
Cameron County benefits staff and an outside consultant told the commissioners court that a small number of high-cost prescription drugs are responsible for a large share of the county’s pharmacy spending.
Efren (last name not specified in record), county benefits director, reported the county completed open enrollment with 1,608 employees and noted pharmacy rebates were higher than expected. Roger Garza of ValueRisk Consulting told the court “the county currently has 6 drugs that are incurring approximately 48% of its entire pharmaceutical cost,” and said those medicines account for about $2.7 million of the plan’s pharmacy expenditures.
Garza and benefits staff said the county has 24 (recently 25) high-claimants, and the plan paid roughly $5.7 million on pharmaceuticals year to date. Garza said his firm has recommendations the court will consider in October to contain costs and that the measures could “save the county approximately about a million dollars a year.” He identified GLP-1–class medications (used for diabetes and weight loss) as the major driver and warned of new, higher-cost drugs coming to market that may further increase costs.
Commissioners discussed policy options. Garza said a plan can impose differential cost-sharing (coinsurance or separate copays) for a drug class but must apply measures consistently; he described industry approaches such as separate coinsurance tiers to limit exposure. The court asked for more data separating prescriptions written for diabetes from those used for weight loss; Garza and staff said they would return with further breakdowns at the next meeting.
No policy changes were approved at this meeting. The court voted to acknowledge the briefing. The benefits office said three stop‑loss RFP responses were received and that the county will bring recommendations and contract renewal items back to the court next month for possible action.
